SORBITAN MONOSTEARATE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 431.0 | 4.3 | 3 | 6 | 96.0 | 19 | 0.96 |
- CAS
- 1338416
- UNII
- NVZ4I0H58X
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 4 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Functions of Sorbitan Monostearate
| Af - Antifoaming (or defoaming) agent |
| Ctg - Component or coating |
| Emul - Emulsifier |
| Feed - Feed additives |
Regulatory Status of Sorbitan Monostearate
| Fs - Substances permitted as optional ingredient in a standardized food. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Suspension | 1.25% |
| Topical | Cream, Augmented | 2%W/W |
| Topical | Cream, Emulsion, Sustained Release | 5% |
| Topical | Emulsion, Cream | 6% |
| Topical | Lotion | 2.5%W/W |
| Topical | Ointment | |
| Topical | Solution | |
| Topical | Suppository, Insert | |
| Topical | Suspension | 2.15% |
| Topical | Tablet | |
| Vaginal | Cream, Augmented | 2% |
| Vaginal | Emulsion, Cream | 5% |
| Vaginal | Suppository, Insert | |
| Vaginal | Tablet |